NASDAQ:ANABAnaptysBio Stock Price, Forecast & News

AnaptysBio's stock was trading at $15.23 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, ANAB stock has increased by 48.2% and is now trading at $22.57. View which stocks have been most impacted by Coronavirus.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AnaptysBio in the last year. There are currently 1 sell rating, 6 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for AnaptysBio.

AnaptysBio is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020. View our earnings forecast for AnaptysBio.

AnaptysBio Inc (NASDAQ:ANAB) announced its quarterly earnings results on Wednesday, May, 6th. The biotechnology company reported ($0.30) earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of ($0.63) by $0.33. The biotechnology company earned $15 million during the quarter, compared to the consensus estimate of $10 million. View AnaptysBio's earnings history.

8 equities research analysts have issued 12-month target prices for AnaptysBio's stock. Their forecasts range from $12.00 to $140.00. On average, they expect AnaptysBio's stock price to reach $36.00 in the next year. This suggests a possible upside of 59.5% from the stock's current price. View analysts' price targets for AnaptysBio.

Media coverage about ANAB stock has trended very negative this week, according to InfoTrie Sentiment Analysis. InfoTrie ranks the sentiment of news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. AnaptysBio earned a media sentiment score of -3.3 on InfoTrie's scale. They also assigned media stories about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View the latest news about AnaptysBio.

Some companies that are related to AnaptysBio include Opko Health (OPK), Turning Point Therapeutics (TPTX), IGM Biosciences (IGMS), Pacira Biosciences (PCRX), TG Therapeutics (TGTX), SAGE Therapeutics (SAGE), Uniqure (QURE), Principia Biopharma (PRNB), Corcept Therapeutics (CORT), INDIVIOR PLC/S (INVVY), Dicerna Pharmaceuticals (DRNA), Prestige Consumer Healthcare (PBH), Xencor (XNCR), Eidos Therapeutics (EIDX) and Aurinia Pharmaceuticals (AUPH). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other AnaptysBio investors own include Crispr Therapeutics (CRSP), ImmunoGen (IMGN), Editas Medicine (EDIT), NVIDIA (NVDA), Amarin (AMRN), Alibaba Group (BABA), bluebird bio (BLUE), Baozun (BZUN), Canopy Growth (CGC) and Clovis Oncology (CLVS).

(ANAB) raised $60 million in an IPO on Thursday, January 26th 2017. The company issued 4,000,000 shares at a price of $14.00-$16.00 per share. Credit Suisse and Stifel served as the underwriters for the IPO and JMP Securities and Wedbush PacGrow were co-managers.

AnaptysBio trades on the NASDAQ under the ticker symbol "ANAB."

Shares of ANAB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of ANAB stock can currently be purchased for approximately $22.57.

AnaptysBio has a market capitalization of $615.71 million and generates $8 million in revenue each year. The biotechnology company earns $-97,340,000.00 in net income (profit) each year or ($3.60) on an earnings per share basis. AnaptysBio employs 78 workers across the globe.

The official website for AnaptysBio is www.anaptysbio.com.

AnaptysBio's mailing address is 10421 PACIFIC CENTER COURT SUITE 200, SAN DIEGO CA, 92121. The biotechnology company can be reached via phone at 858-362-6295 or via email at [email protected]